Frank Barnhart

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

Mark T. Dransfield, Jean Bourbeau, Paul Jones et al. · The Lancet Respiratory Medicine · 2013 · 359 citations

Medicine, Internal Medicine, Pharmacotherapy +13

Pneumonia Risk with Inhaled Fluticasone Furoate and Vilanterol Compared with Vilanterol Alone in Patients with COPD

Courtney Crim, Mark T. Dransfield, Jean Bourbeau et al. · Annals of the American Thoracic Society · 2014 · 155 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

The Efficacy and Safety of the Novel Long-Acting β2 Agonist Vilanterol in Patients With COPD

Nicola A. Hanania, Gregory Feldman, W. Zachgo et al. · CHEST Journal · 2012 · 105 citations

Medicine, Pharmacology, Pharmacotherapy +14

Switching from Ventolin CFC to Ventolin HFA is well tolerated and effective in patients with asthma

William R. Lumry, Robert J. Noveck, Steven F. Weinstein et al. · Annals of Allergy Asthma & Immunology · 2001 · 26 citations

Medicine, Internal Medicine, Allergy +7